-
Oncology
NICE has today issued guidance to the NHS in England in Wales recommending rituximab as an option for the treatment of patients with symptomatic stage III and IV follicular lymphoma who have previously been untreated.
National Institute for Health and Clinical Excellence - Wed, 27 September 2006
http://www.nice.org.uk
-
Coloproctology
Researchers from the Johns Hopkins University and other institutions have developed a new prediction model for genetic defects known as Lynch syndrome, which predisposes families to developing colorectal cancer.
Johns Hopkins Hospital - Tue, 26 September 2006
http://www.hopkinshospital.org
-
Cardiology
Blood lead levels currently thought to be safe by the U.S. government, the World Health Organization and many other authorities are associated with an increased risk of heart attack and stroke
Johns Hopkins Hospital - Wed, 20 September 2006
http://www.hopkinshospital.org
-
Epidemiology
O objetivo desta revisão sistemática foi avaliar os estudos analíticos que relacionaram a doença periodontal como possível fator de risco para desfechos indesejáveis da gestação.
Cadernos de Saúde Pública - Thu, 7 September 2006
http://www.scielo.br
-
Infectious Diseases
La llegada de la terapia antirretroviral de gran actividad (TARGA) ha reducido la mortalidad y mejorado la calidad de vida de las personas VIH positivas, pero el tratamiento del virus y de las enfermedades que provoca sigue siendo muy complejo.
Boletín de Tratamientos Experimentales Contra el SIDA - Tue, 5 September 2006
http://www.sfaf.org
-
Allergology
Cow milk allergy (CMA) is as an immunologically mediated adverse reaction to one or more cow's milk proteins: in some children the ingestion of milk can trigger the body into launching an inappropriate immune response to the proteins in milk resulting in an allergic reaction.
Act Against Allergy - Fri, 1 September 2006
http://www.actagainstallergy.co.uk